Celia Miralles

2.1k total citations
53 papers, 1.2k citations indexed

About

Celia Miralles is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Celia Miralles has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 21 papers in Virology and 17 papers in Epidemiology. Recurrent topics in Celia Miralles's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (21 papers) and HIV/AIDS Research and Interventions (15 papers). Celia Miralles is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (21 papers) and HIV/AIDS Research and Interventions (15 papers). Celia Miralles collaborates with scholars based in Spain, United Kingdom and United States. Celia Miralles's co-authors include Antonio Ocampo, Santiago Moreno, Mariano Provencio, Blanca Cantos, Peré Domingo, Elena Losada, Vincent Soriano, Pablo Barreiro, Marina Núñez and Lucía Pérez-Álvarez and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Clinical Chemistry.

In The Last Decade

Celia Miralles

53 papers receiving 1.1k citations

Peers

Celia Miralles
Marialuisa Partisani France
Nicoletta Ladisa Italy
Elizabeth Taylor Canada
Jean‐Jacques Lefrère France
Jordi Navarro Spain
Julie Galimand France
Masakazu Matsuda Japan
H Jablonowski Germany
Joshua Vasquez United States
Ignacio de los Santos Spain
Marialuisa Partisani France
Celia Miralles
Citations per year, relative to Celia Miralles Celia Miralles (= 1×) peers Marialuisa Partisani

Countries citing papers authored by Celia Miralles

Since Specialization
Citations

This map shows the geographic impact of Celia Miralles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia Miralles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia Miralles more than expected).

Fields of papers citing papers by Celia Miralles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celia Miralles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia Miralles. The network helps show where Celia Miralles may publish in the future.

Co-authorship network of co-authors of Celia Miralles

This figure shows the co-authorship network connecting the top 25 collaborators of Celia Miralles. A scholar is included among the top collaborators of Celia Miralles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia Miralles. Celia Miralles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez‐González, Alexandre, Eva Poveda, Joaquı́n González-Carreró, et al.. (2023). Anal Dysplasia Screening in People Living with HIV: Long-Term Follow-Up in a Large Cohort from Northwest Spain. AIDS Patient Care and STDs. 38(1). 5–13. 3 indexed citations
2.
3.
Luna, J., et al.. (2021). Recent advances in early stage lung cancer. Journal of Clinical and Translational Research. 7(2). 163–174. 9 indexed citations
4.
Rallón, Norma, Judit Morelló, Pablo Labarga, et al.. (2011). Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C. Clinical Infectious Diseases. 53(12). 1291–1295. 10 indexed citations
5.
Vispo, Eugenia, Pablo Labarga, Josep M. Guardiola, et al.. (2010). Preemptive Erythropoietin Plus High Ribavirin Doses to Increase Rapid Virological Responses in HIV Patients Treated for Chronic Hepatitis C. AIDS Research and Human Retroviruses. 26(4). 419–424. 5 indexed citations
6.
Fernández-García, Aurora, Lucía Pérez-Álvarez, María Teresa Cuevas, et al.. (2010). Identification of a New HIV Type 1 Circulating BF Intersubtype Recombinant Form (CRF47_BF) in Spain. AIDS Research and Human Retroviruses. 26(7). 827–832. 28 indexed citations
7.
Antela, Antonio, Antonio Ocampo, María Jesús López, et al.. (2010). Liver Toxicity After Switching or Simplifying to Nevirapine-Based Therapy Is Not Related to CD4 Cell Counts: Results of the TOSCANA Study. HIV Clinical Trials. 11(1). 11–17. 7 indexed citations
8.
Llibre, Josep M., Antonio Antela, José Ramón Arribas, et al.. (2010). El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1. Enfermedades Infecciosas y Microbiología Clínica. 28(9). 615–620. 5 indexed citations
9.
Cuevas, María Teresa, Aurora Fernández-García, Michael M. Thomson, et al.. (2010). Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment. AIDS Research and Human Retroviruses. 26(9). 1019–1025. 19 indexed citations
10.
Llibre, Josep M., Vicenç Falcó, Cristina Tural, et al.. (2009). The Changing Face of HIV/AIDS in Treated Patients. Current HIV Research. 7(4). 365–377. 20 indexed citations
11.
Pérez-Álvarez, Lucía, Valentina E. Garcia, Antonio Ocampo, et al.. (2008). HIV Type 1 Intersubtype Recombinants during the Evolution of a Dual Infection with Subtypes B and G. AIDS Research and Human Retroviruses. 24(2). 337–343. 7 indexed citations
12.
Núñez, Marina, Celia Miralles, Elena Losada, et al.. (2007). Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial. AIDS Research and Human Retroviruses. 23(8). 972–982. 144 indexed citations
13.
Pérez-Álvarez, Lucía, Elena Delgado, Celia Miralles, et al.. (2006). Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain. Journal of Medical Virology. 78(12). 1520–1528. 14 indexed citations
14.
Llibre, Josep M., Peré Domingo, Rosario Palacios, et al.. (2006). Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir. AIDS. 20(10). 1407–1414. 68 indexed citations
15.
Pérez-Álvarez, Lucía, Rocío Carmona, Antonio Ocampo, et al.. (2005). Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1. Journal of Medical Virology. 78(2). 141–147. 40 indexed citations
16.
Bonjoch, Anna, Roger Paredes, Juan Gálvez-Acebal, et al.. (2005). Antiretroviral Treatment Simplification With 3 NRTIs or 2 NRTIs Plus Nevirapine in HIV-1-Infected Patients Treated With Successful First-Line HAART. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(3). 313–316. 17 indexed citations
17.
Delgado, Elena, Michael M. Thomson, María Luisa Villahermosa, et al.. (2002). Identification of a Newly Characterized HIV-1 BG Intersubtype Circulating Recombinant Form in Galicia, Spain, Which Exhibits a Pseudotype-Like Virion Structure. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5). 536–543. 75 indexed citations
18.
Domínguez, Gemma, Javier Silva, José M. Silva, et al.. (2000). Clinicopathological characteristics of breast carcinomas with allelic loss in the p73. Breast Cancer Research and Treatment. 63(1). 17–22. 7 indexed citations
19.
Bordón, José, et al.. (1995). Neurosyphilis in HIV-infected patients. European Journal of Clinical Microbiology & Infectious Diseases. 14(10). 864–869. 38 indexed citations
20.
Monje, Florencio, et al.. (1994). Changes in the temporomandibular joint caused by the vertical facial pattern. Study on an experimental model. Journal of Cranio-Maxillofacial Surgery. 22(6). 361–370. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marialuisa Partisani Breakdown of academic impact, for papers by Nicoletta Ladisa Breakdown of academic impact, for papers by Elizabeth Taylor Breakdown of academic impact, for papers by Jean‐Jacques Lefrère Breakdown of academic impact, for papers by Jordi Navarro Breakdown of academic impact, for papers by Julie Galimand Breakdown of academic impact, for papers by Masakazu Matsuda Breakdown of academic impact, for papers by H Jablonowski Breakdown of academic impact, for papers by Joshua Vasquez Breakdown of academic impact, for papers by Ignacio de los Santos
Rankless by CCL
2026